EAPH News Thursday, June 5, 2014 9:18:56 PM $EAPH
Easton Pharmaceuticals Announces New Non-Dilutional Financing Source to Be Utilized Towards Its Medical Marijuana Initiative and Acquisitions
Marketwire - Thu Jun 05, 2:06AM CDT
Easton Pharmaceuticals Inc. (OTC: EAPH) announces it has located a new source of non-dilutional financing.
OTC Trading Sector Focus List: Abakan, Inc. MyECheck, Inc. Easton Pharmaceuticals, MRI Interventions, Infinex Ventures
PR Newswire - Wed Jun 04, 7:58AM CDT
Trading in the small cap markets over the summer in be a volatile time and the close yesterday was no exception. Today we focus on a group of stocks trading within the OTC that were substantially higher but may have pulled back intra-day due to profit taking from traders therefore making a cheaper price entry point.
Easton Pharmaceuticals signs agreement to purchase an ownership interest in a medical marijuana operation in Canada
M2 - Tue Jun 03, 4:10AM CDT
Easton Pharmaceuticals Inc (OTC: EAPH), a specialty pharmaceutical company involved in various pharmaceutical sectors including medical marijuana, announced on Monday the signing of an agreement to purchase an interest in a pending medical marijuana operation.
Easton Pharmaceuticals Announces the Closing of Medical Marijuana Agreement With MDRM Group (Canada) Ltd., on Purchasing an Ownership Interest in a Growers License in Canada's Federal Medical Marijuana Industry
Marketwire - Mon Jun 02, 8:42AM CDT
Easton Pharmaceuticals Inc. (OTC: EAPH) announces it has signed an agreement to purchase an interest in a pending medical marijuana operation.
Optimizing Operations Continue for Legal Marijuana Industry - Company Acquires Option for Cannabis Genetic Catalog for 22 Unique Strains
PR Newswire - Thu May 29, 7:50AM CDT
Cannabis companies dealing with Legal Medical Marijuana Industry continue to make progress by developing products through advancements, acquisitions and research: OSL Holdings (OTC: OSL), Cannabis Science, Inc. (OTC: CBIS), Easton Pharmaceuticals Inc. (OTC: EAPH), GreenGro Technologies, Inc. (OTC: GRNH) and Vape Holdings, Inc. (OTC: VAPE)
CannabisFN Weekly: Water Rights Could Become an Issue for Cannabis Growers
ACCESSWIRE - Tue May 27, 8:01AM CDT
Whitefish, MT / ACCESSWIRE / May 27, 2014 / The Marijuana Index™ moved modestly lower last week amid lackluster performance by bellwethers like GW Pharmaceuticals Ltd. (NASDAQ: GWPH) and CannaVEST Corp. (OTC: CANV), which traded down 0.88% and 69.5%, respectively.
Cannabis Based Medicines Gain Traction as Research & Development Ramp up - Company Looks to Develop Topical Cannabis Medicine to Treat Skin Cancer
PR Newswire - Thu May 15, 7:45AM CDT
Marijuana industry displays versatility as companies diversify products by specializing in developing Cannabis Based medicines: New Colombia Resources, Inc. (OTC: NEWC), Easton Pharmaceuticals Inc. (OTC: EAPH), GW Pharmaceuticals plc (NASDAQ: GWPH), Medical Marijuana, Inc. (OTC: MJNA) and Terra Tech Corp. (OTC: TRTC)
Easton Pharmaceuticals Provides Final Payment to BMV Medica S.A. Towards BMV's Distributorship, Marketing Network and Strategy in the Mexican Market for Its Viorra Product; Signs Medical Marijuana Proposal Document
Marketwire - Wed May 07, 5:26AM CDT
Easton Pharmaceuticals Inc. (OTC: EAPH) announces it had provided BMV Medica S.A. de C.V. confirmation of final payment to BMV towards it Mexican initiatives regarding Easton's Viorra product. Announces new Michigan proposal in its medical marijuana initiatives.
3D Eye Solutions Inc. Enters e-Cigarette Business
ACCESSWIRE - Thu Apr 24, 9:26AM CDT
3D Eye Solutions Inc.'s (OTC Pink: TDEY) share volume skyrocketed Apr. 23, with 574,851,584 shares changing hands, more than six times greater than its three-month average volume of 89,224,412 shares.
Easton Pharmaceuticals Receives Final Changes and Nears Completion on Its Reg. A SEC Filing to Raise Up to $5,000,000 in Additional Committed Financing
Marketwire - Wed Apr 23, 7:29AM CDT
Easton Pharmaceuticals Inc. (OTC: EAPH) announces it has received a final draft of its Reg. A SEC document that is set to be filed with the Securities and Exchange Commission later this week.
Colombian Research Involving Cannabiods For Cancer Patients & Pharmaceutical Products Heats Up - Company Announces Appointment of Well Known Medical Marijuana Scientific Advisor
PR Newswire - Tue Apr 22, 7:50AM CDT
Cannabis advancers making strides in product developments and research events: New Colombia Resources, Inc. (OTC: NEWC), Cannabis Science, Inc. (OTC: CBIS), Medical Marijuana, Inc. (OTC: MJNA), Easton Pharmaceuticals, Inc. (OTC: EAPH), Extreme Biodiesel, Inc. (OTC: XTRM) and Next Generation Energy Corp. (OTC: NGMC)
Latteno Food Corp. Opens a Medical-Marijuana Evaluation Office in Los Angeles
ACCESSWIRE - Mon Apr 21, 8:01AM CDT
On Apr. 18, Latteno Food Corp's (OTCPPINK: LATF) enjoyed robust stock volume with 117,999,232 shares changing hands.
Easton Pharmaceuticals Signs "Viorra" Distribution Deal for Mexico
Marketwire - Mon Apr 14, 7:03AM CDT
Easton Pharmaceuticals (OTC: EAPH) is pleased to announce that BMV Medica, S.A. de C.V., a Mexican regulatory company and distributor of pharmaceutical products have signed an exclusive agreement to distribute Easton's "VIORRA" product in Mexico.
Easton Pharmaceuticals Announces Mr. Kent Deuters as Chief Operations Officer and Special Advisor on the Company's Medical Marijuana Initiatives and Other Company Business Segments; Provides Further Updates on Its Medical Marijuana Program
Marketwire - Thu Apr 03, 11:05AM CDT
Easton Pharmaceuticals Inc. (OTC: EAPH) announces the appointment of Mr. Kent A. Deuters to the position of Chief Operations Officer and Special Advisor.
CannabisFN Weekly: Cannabis Sector Gears Up for Canada's MMPR
ACCESSWIRE - Mon Mar 31, 8:01AM CDT
Whitefish, MT / March 31, 2014 / The Marijuana Index™ moved lower over the past week due in large part to a 40% drop in shares of Cannavest Corp. (OTCBB: CANV) along with broader declines across the sector. Many traders appeared to be locking in profits after a volatile start to 2014 although cannabis stocks showed signs of recovery during Friday's session and long-term industry catalysts like regulatory reform remain very intact.
Easton Pharmaceuticals Announces Changes in Management and New Additions to Advisory Board; Appoints Dr. Albert PhD as New Marketing and Technology Officer and Appoints Tim Zorn, Current CEO of HempLifeToday.com to Advisory Board
Marketwire - Mon Mar 31, 7:03AM CDT
Easton Pharmaceuticals Inc. (OTC: EAPH) -- announces it has appointed Carla Pepe as its new CEO and President, replacing John Adams who will assume the position of CFO. The company also announces the addition of Dr. Lilla Albert PhD to the advisory board, chief marketing officer, and Mr. Tim Zorn, current CEO of HempLifeToday.com (OTC: GLCO) to advisory board.
Easton Pharmaceuticals Announces Signing LOI for Joint Venture Towards Private Medical Marijuana Colorado Grower and Licenses; Provides Clarification on Its Canadian Medical Marijuana Initiatives
Marketwire - Fri Mar 28, 9:45AM CDT
Easton Pharmaceuticals Inc. (OTC: EAPH), a specialty pharmaceutical company that owns, designs, develops, and markets an array of topically-delivered drugs and therapeutic / cosmetic healthcare products, today announces it has signed a letter of intent for the creation of a possible JV with another US company towards a Private Medical Marijuana company in the state of Colorado.
Easton Pharmaceuticals Announces Update to Its Cancer Drug Initiative: Majority Acquisition, Patent Strategy and Clinical Development Along With New Partnership Proposal Involving Medicinal Marijuana Drug Development
Marketwire - Tue Mar 25, 7:46AM CDT
Easton Pharmaceuticals, Inc. (OTC: EAPH), a specialty pharmaceutical company that owns, designs, develops, and markets an array of topically-delivered drugs and therapeutic / cosmetic healthcare products, announces it has entered into an agreement towards securing majority control of the cancer drug Xilive, pending certain conditions and a new partnership proposal towards medicinal marijuana.
Cannabis Science Finalizes $1 Million in New Financing
ACCESSWIRE - Wed Mar 19, 10:22AM CDT
A developer of cannabis-based pharmaceutical products Cannabis Science Inc. (NASDAQ OTC: CBIS) announced that it has finalized its $1,000,000 private placement and the funds have already been put into the bank.
Easton Pharmaceuticals Announces New Non-Dilutional Financing Source to Be Utilized Towards Its Medical Marijuana Initiative and Acquisitions
Marketwire - Thu Jun 05, 2:06AM CDT
Easton Pharmaceuticals Inc. (OTC: EAPH) announces it has located a new source of non-dilutional financing.
OTC Trading Sector Focus List: Abakan, Inc. MyECheck, Inc. Easton Pharmaceuticals, MRI Interventions, Infinex Ventures
PR Newswire - Wed Jun 04, 7:58AM CDT
Trading in the small cap markets over the summer in be a volatile time and the close yesterday was no exception. Today we focus on a group of stocks trading within the OTC that were substantially higher but may have pulled back intra-day due to profit taking from traders therefore making a cheaper price entry point.
Easton Pharmaceuticals signs agreement to purchase an ownership interest in a medical marijuana operation in Canada
M2 - Tue Jun 03, 4:10AM CDT
Easton Pharmaceuticals Inc (OTC: EAPH), a specialty pharmaceutical company involved in various pharmaceutical sectors including medical marijuana, announced on Monday the signing of an agreement to purchase an interest in a pending medical marijuana operation.
Easton Pharmaceuticals Announces the Closing of Medical Marijuana Agreement With MDRM Group (Canada) Ltd., on Purchasing an Ownership Interest in a Growers License in Canada's Federal Medical Marijuana Industry
Marketwire - Mon Jun 02, 8:42AM CDT
Easton Pharmaceuticals Inc. (OTC: EAPH) announces it has signed an agreement to purchase an interest in a pending medical marijuana operation.
Optimizing Operations Continue for Legal Marijuana Industry - Company Acquires Option for Cannabis Genetic Catalog for 22 Unique Strains
PR Newswire - Thu May 29, 7:50AM CDT
Cannabis companies dealing with Legal Medical Marijuana Industry continue to make progress by developing products through advancements, acquisitions and research: OSL Holdings (OTC: OSL), Cannabis Science, Inc. (OTC: CBIS), Easton Pharmaceuticals Inc. (OTC: EAPH), GreenGro Technologies, Inc. (OTC: GRNH) and Vape Holdings, Inc. (OTC: VAPE)
CannabisFN Weekly: Water Rights Could Become an Issue for Cannabis Growers
ACCESSWIRE - Tue May 27, 8:01AM CDT
Whitefish, MT / ACCESSWIRE / May 27, 2014 / The Marijuana Index™ moved modestly lower last week amid lackluster performance by bellwethers like GW Pharmaceuticals Ltd. (NASDAQ: GWPH) and CannaVEST Corp. (OTC: CANV), which traded down 0.88% and 69.5%, respectively.
Cannabis Based Medicines Gain Traction as Research & Development Ramp up - Company Looks to Develop Topical Cannabis Medicine to Treat Skin Cancer
PR Newswire - Thu May 15, 7:45AM CDT
Marijuana industry displays versatility as companies diversify products by specializing in developing Cannabis Based medicines: New Colombia Resources, Inc. (OTC: NEWC), Easton Pharmaceuticals Inc. (OTC: EAPH), GW Pharmaceuticals plc (NASDAQ: GWPH), Medical Marijuana, Inc. (OTC: MJNA) and Terra Tech Corp. (OTC: TRTC)
Easton Pharmaceuticals Provides Final Payment to BMV Medica S.A. Towards BMV's Distributorship, Marketing Network and Strategy in the Mexican Market for Its Viorra Product; Signs Medical Marijuana Proposal Document
Marketwire - Wed May 07, 5:26AM CDT
Easton Pharmaceuticals Inc. (OTC: EAPH) announces it had provided BMV Medica S.A. de C.V. confirmation of final payment to BMV towards it Mexican initiatives regarding Easton's Viorra product. Announces new Michigan proposal in its medical marijuana initiatives.
3D Eye Solutions Inc. Enters e-Cigarette Business
ACCESSWIRE - Thu Apr 24, 9:26AM CDT
3D Eye Solutions Inc.'s (OTC Pink: TDEY) share volume skyrocketed Apr. 23, with 574,851,584 shares changing hands, more than six times greater than its three-month average volume of 89,224,412 shares.
Easton Pharmaceuticals Receives Final Changes and Nears Completion on Its Reg. A SEC Filing to Raise Up to $5,000,000 in Additional Committed Financing
Marketwire - Wed Apr 23, 7:29AM CDT
Easton Pharmaceuticals Inc. (OTC: EAPH) announces it has received a final draft of its Reg. A SEC document that is set to be filed with the Securities and Exchange Commission later this week.
Colombian Research Involving Cannabiods For Cancer Patients & Pharmaceutical Products Heats Up - Company Announces Appointment of Well Known Medical Marijuana Scientific Advisor
PR Newswire - Tue Apr 22, 7:50AM CDT
Cannabis advancers making strides in product developments and research events: New Colombia Resources, Inc. (OTC: NEWC), Cannabis Science, Inc. (OTC: CBIS), Medical Marijuana, Inc. (OTC: MJNA), Easton Pharmaceuticals, Inc. (OTC: EAPH), Extreme Biodiesel, Inc. (OTC: XTRM) and Next Generation Energy Corp. (OTC: NGMC)
Latteno Food Corp. Opens a Medical-Marijuana Evaluation Office in Los Angeles
ACCESSWIRE - Mon Apr 21, 8:01AM CDT
On Apr. 18, Latteno Food Corp's (OTCPPINK: LATF) enjoyed robust stock volume with 117,999,232 shares changing hands.
Easton Pharmaceuticals Signs "Viorra" Distribution Deal for Mexico
Marketwire - Mon Apr 14, 7:03AM CDT
Easton Pharmaceuticals (OTC: EAPH) is pleased to announce that BMV Medica, S.A. de C.V., a Mexican regulatory company and distributor of pharmaceutical products have signed an exclusive agreement to distribute Easton's "VIORRA" product in Mexico.
Easton Pharmaceuticals Announces Mr. Kent Deuters as Chief Operations Officer and Special Advisor on the Company's Medical Marijuana Initiatives and Other Company Business Segments; Provides Further Updates on Its Medical Marijuana Program
Marketwire - Thu Apr 03, 11:05AM CDT
Easton Pharmaceuticals Inc. (OTC: EAPH) announces the appointment of Mr. Kent A. Deuters to the position of Chief Operations Officer and Special Advisor.
CannabisFN Weekly: Cannabis Sector Gears Up for Canada's MMPR
ACCESSWIRE - Mon Mar 31, 8:01AM CDT
Whitefish, MT / March 31, 2014 / The Marijuana Index™ moved lower over the past week due in large part to a 40% drop in shares of Cannavest Corp. (OTCBB: CANV) along with broader declines across the sector. Many traders appeared to be locking in profits after a volatile start to 2014 although cannabis stocks showed signs of recovery during Friday's session and long-term industry catalysts like regulatory reform remain very intact.
Easton Pharmaceuticals Announces Changes in Management and New Additions to Advisory Board; Appoints Dr. Albert PhD as New Marketing and Technology Officer and Appoints Tim Zorn, Current CEO of HempLifeToday.com to Advisory Board
Marketwire - Mon Mar 31, 7:03AM CDT
Easton Pharmaceuticals Inc. (OTC: EAPH) -- announces it has appointed Carla Pepe as its new CEO and President, replacing John Adams who will assume the position of CFO. The company also announces the addition of Dr. Lilla Albert PhD to the advisory board, chief marketing officer, and Mr. Tim Zorn, current CEO of HempLifeToday.com (OTC: GLCO) to advisory board.
Easton Pharmaceuticals Announces Signing LOI for Joint Venture Towards Private Medical Marijuana Colorado Grower and Licenses; Provides Clarification on Its Canadian Medical Marijuana Initiatives
Marketwire - Fri Mar 28, 9:45AM CDT
Easton Pharmaceuticals Inc. (OTC: EAPH), a specialty pharmaceutical company that owns, designs, develops, and markets an array of topically-delivered drugs and therapeutic / cosmetic healthcare products, today announces it has signed a letter of intent for the creation of a possible JV with another US company towards a Private Medical Marijuana company in the state of Colorado.
Easton Pharmaceuticals Announces Update to Its Cancer Drug Initiative: Majority Acquisition, Patent Strategy and Clinical Development Along With New Partnership Proposal Involving Medicinal Marijuana Drug Development
Marketwire - Tue Mar 25, 7:46AM CDT
Easton Pharmaceuticals, Inc. (OTC: EAPH), a specialty pharmaceutical company that owns, designs, develops, and markets an array of topically-delivered drugs and therapeutic / cosmetic healthcare products, announces it has entered into an agreement towards securing majority control of the cancer drug Xilive, pending certain conditions and a new partnership proposal towards medicinal marijuana.
Cannabis Science Finalizes $1 Million in New Financing
ACCESSWIRE - Wed Mar 19, 10:22AM CDT
A developer of cannabis-based pharmaceutical products Cannabis Science Inc. (NASDAQ OTC: CBIS) announced that it has finalized its $1,000,000 private placement and the funds have already been put into the bank.
